We treated pancreatic cancer cells (Panc1 and MiaPaCa) with various doses of gemcitabine (0–10 μM) in the presence and absence of CXCL12 (100 ng ml−1) in serum-containing media. Here, CXCL12 is linked to familial pancreatic carcinoma.